(Q46913599)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17984161%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Role of paroxetine in interferon-alpha-induced immune and behavioural changes in male Wistar rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17984161%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17984161%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Marta Kubera

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17984161%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Myint AM

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17984161%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Kim YK

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17984161%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Kenny C

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17984161%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Kaim-Basta A

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17984161%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Steinbusch HW

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17984161%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Leonard BE

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17984161%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

1 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17984161%20AND%20SRC:MED&resulttype=core&format=json

Journal of Psychopharmacology

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17984161%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17984161%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17984161%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

843-850

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17984161%20AND%20SRC:MED&resulttype=core&format=json

Effects of chronic administration of interferon alpha A/D on serotonergic receptors in rat brain

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

The interferons. Mechanisms of action and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Differential roles of tumor necrosis factor-alpha and interleukin-1 beta in lipopolysaccharide-induced brain injury in the neonatal rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Recombinant human interferon-alpha does not alter reward behavior, or neuroimmune and neuroendocrine activation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Side effects of alpha interferon in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Modulation of TNF-alpha mRNA production in rat C6 glioma cells by TNF-alpha, IL-1beta, IL-6, and IFN-alpha: in vitro analysis of cytokine-cytokine interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Comparison of the Lowry and the Bradford protein assays as applied for protein estimation of membrane-containing fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Paroxetine for the prevention of depression induced by interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Acute tryptophan depletion induced by a gelatin-based mixture impairs object memory but not affective behavior and spatial learning in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Effects of interferon and ribavirin combination therapy on CD4+ proliferation, lymphocyte activation, and Th1 and Th2 cytokine profiles in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Neurotoxicity of intraventricularly administered alpha-interferon for leptomeningeal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Persistent neurotoxicity of systemically administered interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Paroxetine for the prevention of depression induced by high-dose interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Th1, Th2, and Th3 cytokine alterations in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Behavioral assessment of patients treated with alpha-interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Peripheral and central proinflammatory cytokine response to a severe acute stressor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Efavirenz induces depressive-like behaviour, increased stress response and changes in the immune response in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Reversible cognitive decline during high-dose alpha-interferon treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Metrifonate improves working but not reference memory performance in a spatial cone field task

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Effects of myocardial infarction and captopril therapy on anxiety-related behaviors in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Central nervous system toxicity of interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Antidepressant reversal of interferon-alpha-induced anhedonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Acute interferon-alpha administration modulates sucrose consumption in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Interferon alpha (IFNalpha) and psychiatric syndromes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Protein estimation in tissues containing high levels of lipid: Modifications to Lowry's method of protein determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive-depressive changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165

Reduced platelet serotonin in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107077165